• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
AIDS Update 2009

Zobacz nowsze wydanie:

AIDS Update 2011

AIDS Update 2009

9780073527598
308,64 zł
277,77 zł Zniżka 30,87 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 277,77 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
AIDS UPDATE 2009 presents a balanced review of current research and information on HIV infection, HIV disease, and AIDS. AIDS UPDATE 2009 places discussion within a biological, medical, and social framework, helping readers more fully understand this devastating pandemic.
Szczegóły produktu
45986
9780073527598
9780073527598

Opis

Rok wydania
2009
Numer wydania
18
Oprawa
miękka foliowana
Liczba stron
512
Wymiary (mm)
183 x 229
Waga (g)
810
  • Contents

    About the Author iii

    A Quarter Century of AIDS and Counting:: A Humanitarian Crisis ix

    AIDS UPDATE 2009 xvi

    Preface xviii

    Introduction:: Histories of Global

    Pandemics, AIDS, Its Place in History, Overview of HIV/AIDS, International AIDS Conferences and Means of Remembering the AIDS Quilt, Candlelight Memorial, and World AIDS Day 1

    Three Words Echo Around the World:: AIDS Crisis Worsens! 1

    History of Global Pandemics and Epidemics 1

    Fear, Ignorance and Condemnation::

    Who Is to Blame? 2

    Imagine a World Without AIDS 2

    Overview of HIV/AIDS 4

    AIDS:: A Unique Disease 5

    AIDS:: A Cause of Death 5

    Another Anniversary 6

    A New Anniversary 6

    International AIDS Conferences 6

    Means of Remembering 7

    The 25th Candlelight Memorial 9

    Walking to Change the Course of the HIV/AIDS Epidemic United States 10

    Bicycle Riding to Change the Course of the HIV/AIDS Epidemic United States 12

    World AIDS Day:: An International Day of Coordinated Action:: A Time to Recharge and Reconnect 12

    The World Health and UNAIDS Organizations 14

    The Future 14

    National AIDS Hotlines 16

    Useful Internet Addresses 16

    1 AIDS:: Defining the Disease and Finding Its Cause 19

    The New Millennium 19

    AIDS:: A Disease or a Syndrome? 20

    First Reaction to AIDS:: Denial 21

    What Causes AIDS? 22

    How Does HIV Cause AIDS? 23

    The Centers for Disease Control and Prevention Reports 25

    Discovery of the AIDS Virus 25

    Defining the Illness:: AIDS Surveillance 27

    Summary 29

    Review Questions 29

    2 What Causes AIDS:: Origin of the AIDS Virus 30

    The Cause of AIDS:: The Human Immunodeficiency Virus (HIV) 30

    Evidence That HIV Causes AIDS 35

    Origin of HIV:: The AIDS Virus 37

    Summary on the Origin of HIV 43

    Summary 44

    Review Questions 44

    3 Biological Characteristics of the AIDS Virus 46

    Viruses Need a Host Cell in Order to Reproduce 46

    Viruses Are Parasites 46

    Viruses Specific to Cell Type 47

    Retroviruses 47

    Description of HIV; How It Attaches to a Host Cell and Buds Out of the Cell 47

    Human Immunodeficiency Virus (HIV):: Its Life Cycle 50

    The HIV Life Cycle 50

    How HIV Escapes the Infected Cell 52

    Basic Genetic Structure of Retroviral Genomes 54

    Genetic Revolution 59

    Formation of Genetic Recombination in HIV 59

    Distinct Genotypes (Subtypes/Clades) of HIV-1 Worldwide Based on ENV and GAG Proteins 60

    Summary 63

    Review Questions 63

    4 Anti-HIV Therapy 65

    Anti-HIV Therapy 66

    HIV Eradication Update 2008 67

    Antiretroviral Therapy (ART) Drugs with FDA Approval 67

    The HIV Medicine Chest:: ART Drugs Receiving FDA Approval 69

    FDA-Approved Nucleoside/Non-Nucleoside Analog Reverse Transcriptase Inhibitors and Protease Inhibitors 71

    Use of Non-Nucleoside Analog Reverse Transcriptase Inhibitors 74

    FDA-Approved Protease Inhibitors 74

    Protease Inhibitors 74

    Entry Inhibitors and Problems 76

    Integrase Inhibitors 77

    Development and Selection of HIV Drug-Resistant Mutants 78

    Development of HIV Drug Resistance to Protease Inhibitors 78

    How Combination Drug Therapy Can Reduce the Chance of HIV Drug Resistance 82

    HIV Treatment Regimen Failure 83

    Viral Load:: Its Relationship to HIV Disease and AIDS 88

    Medical Complications Associated with Anti-HIV Drug Therapies (ART) 88

    The Smart Trial Was Cancelled onJanuary 11, 2006 97

    Novel Drugs 97

    Disclaimer 97

    Summary 99

    Some AIDS Therapy Information Hotlines 100

    Review Questions 101

    5 The Immunology of HIV Disease/AIDS 103

    The Immune System 103

    Human Lymphocytes:: T Cells and B Cells 105

    Antibodies and HIV Disease 113

    Cellular Micro-RNAs Contribute to HIV Latency in Resting Primary CD4+ T Cells 115

    Immune System Dysfunction 115

    Original Antigenic Sin 117

    The Search for Additional Receptors (Coreceptors) to CD4:: FUSIN or CXCKR-4 (R-4) 118

    CCKR-5 (R-5) Receptor 118

    Emergence of HIV Strains That Vary in Their Lethal Abilities 119

    In Search of Genetic Resistance to HIV Infection 119

    T4 Cell Depletion and Immune Suppression 122

    Impact of T4 Cell Depletion 122

    Role of Monocytes and Macrophages in HIV Infection 123

    Where Do T4 or CD4+ Cells Become HIV Infected? 124

    Summary 127

    Review Questions 127

    6 Opportunistic Infections and Cancers Associated with HIV Disease/AIDS 128

    What Is an Opportunistic Disease? 128

    The Prevalence of Opportunistic Diseases 129

    Opportunistic Infections in HIV-Infected People 129

    TB and HIV 140

    Cancer or Malignancy in HIV/AIDS Patients 140

    Disclaimer 145

    Summary 145

    Review Questions 145

    7 A Profile of Biological Indicators for HIV Disease and Progression to AIDS 146

    HIV Disease Defined 146

    Stages of HIV Disease (Without Drug Therapy) 150

    HIV Disease Without Symptoms, with Symptoms, and AIDS 156

    Production of HIV-Specific Antibodies 157

    Prognostic Biological Markers Related to AIDS Progression 161

    HIV Infection of the Central Nervous System (CNS) 167

    Neuropathies in HIV Disease/AIDS Patients 168

    Pediatric Clinical Signs and Symptoms 169

    Summary 170

    Review Questions 171

    8 Epidemiology and Transmissionof the Human Immunodeficiency Virus 172

    We Must Stop HIV Transmission Now! 174

    Epidemiology of HIV Infection 174

    Transmission of Two Strains of HIV (HIV-1/HIV-2) 175

    Is HIV Transmitted by Insects? 175

    HIV Transmission 176

    HIV Transmission in Family/Household Settings 178

    Noncasual Transmission 178

    Gay Men Putting Themselves at High Risk for HIV Infection 189

    Problem 194

    Injection-Drug Users and HIV Transmission 198

    United States:: HeterosexualInjection-Drug Use (idU) 202

    Cesarean Section 215

    Conclusion 216

    National AIDS Resources 216

    Summary 217

    Challenge Your Assumptions about the HIV Infected 217

    Review Questions 217

    9 Preventing the Transmission of HIV 219

    The AIDS Generation:: I Knew Everything About It, and I Still Got It! 220

    Prevention, Not Treatment, Is the Least Expensive and Most Effective Way to Stop the Spread of HIV/AIDS 220

    Global Prevention 221

    Antiretroviral Drugs Having an Impact on Prevention, but We Cant Treat Our Way Out of This Pandemic 222

    Advancing HIV Prevention:: New Strategies for a Changing Epidemic 224

    Preventing the Transmission of HIV 226

    Sexual Risk Taking Depends on Sexual Activity 229

    New Rules to an Old Game:: Promoting Safer Sex Nobody Has a Body to Die for! 231

    The Male Condom 234

    The Female Condom or Femidom(Vaginal Pouch) 240

    An Alternative to Condoms:: Vaginal Microbicides 242

    Injection-Drug Use and HIV Transmission:: The Twin Epidemics 245

    HIV Prevention for Injection-Drug Users 245

    Lifting the Ban on the Use of Federal Funding to Support Needle Exchange Programs 247

    Prevention of Blood and Blood Product HIV Transmission 248

    Infection Control Procedures 249

    Sexual Partner Notification:: Disclosure 250

    The U.S. Federal Government Has Now Adopted Partner Notification as Its Cornerstone in Its Effort to Help Control the Spread of HIV 251

    The First Human Vaccine:: The Impact of Vaccines on Infectious Diseases 254

    HIV Vaccine Development and Its Role in Prevention 254

    Types of Experimental HIV Vaccines 258

    DNA Vaccine 258

    Problems in the Search for HIV Vaccine 260

    Summary 262

    Review Questions 263

    10 Prevalence of HIV Infections, AIDS Cases, and Deaths Among Select Groups in the United States and in Other Countries 264

    A Word about HIV/AIDS Data 265

    The Millennium:: Year 2009 270

    Formula for Estimating HIV Infections 272

    Behavioral Risk Groups and Statistical Evaluation 274

    Estimates of AIDS Cases and HIV Infection 284

    Newly Infected 286

    Shape of the HIV Pandemic::United States 288

    Shape of AIDS Pandemic::United States 288

    Estimates of Deaths and Years of Potential Life Lost Due to AIDS in the United States 290

    Canada Estimated HIV/AIDS Cases through 2008:: Population 33,310,000 292

    Global Prevalence and Impact of HIV/AIDS 294

    Connected But Separate 296

    WorkforceĐSouth Africa:: Some Examples 298

    Education:: Teachers and StudentsĐ South Africa and Some Countries in Southern Africa 298

    Other HIV/AIDS Time Bombs in Asia:: India, China, and Russia 299

    Summary 303

    Review Questions 303

    11 Prevalence of HIV Infection and AIDS Cases Among Women and Children 305

    AIDS Is Defining the Lives of Millions of Women 306

    Female Vulnerability 306

    Every Day a Tragedy 306

    Triple Jeopardy 306

    Annual International Womens Day March 8 307

    Women:: AIDS and HIV Infections Worldwide 307

    Women:: HIV-Positive and AIDS Cases United States 308

    Childbearing Women 323

    Internet 324

    Pediatric HIV-Positive and AIDS Cases United States:: A Fight We Can Win! 324

    Orphaned Children Due to HIV Infection and AIDS 325

    The Phenomenon of AIDS Orphans 326

    Summary 332

    Review Questions 332

    12 Prevalence of HIV Infection and AIDS Among Young Adults, Ages 13 to 24 334

    Global HIV Infections in Young Adults 334

    Addressing the AIDS Pandemic Among Young Adults 335

    How Large Is the Young Adult Population in the United States? 336

    HIV/AIDS Wont Affect Us! 337

    Estimate of HIV-Infected and AIDS Cases Among Young Adults in the United States 338

    Summary 346

    Internet 346

    Other Useful Sources 346

    Review Questions 346

    13 Testing for Human Immunodeficiency Virus 347

    Determining the Presence of Antibody Produced When HIV Is Present 348

    Requests for HIV Testing 348

    Reasons for HIV Testing 349

    Laboratory Methods for Detecting HIV 350

    ELISA HIV Antibody Test 351

    Western Blot Assay 358

    New ELISA Antibody Testing and Viral Load Procedures Reveal Early versus Late HIV Infection 361

    Rapid HIV Testing 363

    FDA Approves Two Home HIV Antibody Test Kits 367

    Some Screening and Confirmatory Tests for HIV 368

    Deciding Who Should Get an Hiv Test and When 371

    Why Is HIV Test Information Necessary? 372

    Immigration into the United States 372

    Testing, Competency, and Informed Consent 374

    Summary 381

    Review Questions 382

    14 AIDS and Society:: Knowledge, Attitudes, and Behavior 383

    HIV/AIDS Is a Story in Our Lifetime 384

    The New Millennium and HIV/AIDS 385

    HIV/AIDS Is an Unusual Social Disease 385

    Discrimination vs. Compassion and Support 385

    HIV/AIDS Is Here to Stay 386

    AIDS 387

    Blame Someone, DeJa Vu 387

    Fear:: Panic and Hysteria Over the Spread of HIV/AIDS in the United States 388

    Whom Is the General Public to Believe? 389

    AIDS Education and Behavior:: Dissipating Fear with Education 394

    The Character of Society 401

    Dealing with Discrimination:: The Americans with Disabilities Act 406

    Federal and Private Sector Financing:: Creation of an AIDS Industry 408

    U.S. Government Believes HIV/AIDS Is a Threat to National Security 411

    Global HIV/AIDS Funding for Underdeveloped Nations 412

    Forms of U.S. Monetary Assistance for HIV/AIDS 418

    Summary 423

    Review Questions 424

    Answers to Review Questions 425

    Glossary 431

    References 439

    Index 461

Zobacz nowsze wydanie:

AIDS Update 2011
Komentarze (0)